Hematology/Oncology · Glendale, AZ
NPI
1336160241
Since 2006
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5601 W Eugie Ave Ste 106
Glendale, AZ, 85304
Phone (602) 978-6255
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.7M
267,506 services
Medicare patients, 2024
860
Average age 74
Drug cost, 2024
$10.2M
3,112 prescriptions
Company payments, 2025
$2,778
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amol N Rakkar was code J1439 (injection, ferric carboxymaltose, 1 mg), 42,000 times for 28 patients. In total Amol N Rakkar billed 267,506 services in 118 codes, and Medicare paid $4.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 42,000 | 28 | $0.84 | $35K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 33,240 | 12 | $0.06 | $1,889 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,000 | 11 | $44.84 | $717K |
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 7,641 | 47 | $0.01 | $91.64 |
| J0185 Injection, aprepitant, 1 mg | Office | 5,200 | 13 | $1.34 | $6,964 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,380 | 42 | $0.09 | $303 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,270 | 35 | $0.72 | $1,629 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,880 | 23 | $0.25 | $468 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,689 | 14 | $3.55 | $5,996 |
| 85025 Blood Count | Office | 1,679 | 406 | $7.58 | $13K |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,270 | 15 | $2.32 | $2,952 |
| 99214 Office E&M - Established | Office | 1,106 | 497 | $90.64 | $100K |
| 36415 Venipuncture Blood Collection | Office | 1,106 | 357 | $8.64 | $9,551 |
| 96413 Chemotherapy Administration | Office | 858 | 79 | $98.15 | $84K |
| 96367 Intravenous Infusion, Hydration | Office | 505 | 58 | $21.67 | $11K |
By year: 2022 $4.4M for 259,478 services; 2023 $4.4M for 273,490 services; 2024 $4.7M for 267,506 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,679 | 406 | $7.58 | $13K |
| 36415 Venipuncture Blood Collection | 1,106 | 357 | $8.64 | $9,551 |
| 85610 Clinical Chemistry | 172 | 23 | $4.10 | $706 |
Medicare prescription drug claims, 2024
In 2024, the drug Amol N Rakkar prescribed most often to Medicare patients was Eliquis (Apixaban), with 218 prescriptions and refills. In total Amol N Rakkar wrote 3,112 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 218 | 272 | 51 | $161K |
| Letrozole Generic | 205 | 511 | 65 | $5,004 |
| Xtandi Enzalutamide | 193 | 193 | 28 | $2.6M |
| Warfarin Sodium Generic | 190 | 381 | 45 | $1,086 |
| Prednisone Generic | 158 | 229 | 55 | $699 |
| Ondansetron Odt Ondansetron | 107 | 107 | 65 | $2,204 |
| Xarelto Rivaroxaban | 103 | 151 | 27 | $80K |
| Levothyroxine Sodium Generic | 100 | 180 | 23 | $615 |
| Abiraterone Acetate Generic | 99 | 105 | 13 | $299K |
| Prochlorperazine Maleate Generic | 98 | 98 | 62 | $1,953 |
| Hydroxyurea Generic | 98 | 205 | 27 | $3,077 |
| Fulvestrant Generic | 88 | 88 | 12 | $33K |
| Cabometyx Cabozantinib S-Malate | 80 | 80 | 12 | $2.0M |
| Procrit Epoetin Alfa | 78 | 78 | Under 11 | $143K |
| Oxycodone Hcl Generic | 77 | 77 | 32 | $1,128 |
Brand drugs: - claims; generic drugs: 1,911 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amol N Rakkar $2,778 ($2,778 in general payments such as food, travel and fees) from 39 companies. The largest payer was Janssen Biotech, Inc. with $229.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 11 | $229 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $228 |
| Pfizer Inc. PFE | 10 | $191 |
| Celgene Corporation BMY | 9 | $188 |
| Merck Sharp & Dohme LLC MRK | 7 | $179 |
| Incyte Corporation INCY | 7 | $167 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $152 |
| Abbvie Inc. ABBV | 6 | $145 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $145 |
| Exelixis Inc. EXEL | 3 | $84.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.